This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
TSUB.F Overzicht aandelen
Engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Tsubota Laboratory Incorporated Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | JP¥4.35 |
| 52 Week Hoogtepunt | JP¥4.35 |
| 52 Week Laag | JP¥4.35 |
| Bèta | 0 |
| 11 maand verandering | 0% |
| 3 maanden verandering | n/a |
| 1 Jaar Verandering | n/a |
| 33 jaar verandering | n/a |
| 5 jaar verandering | n/a |
| Verandering sinds IPO | 0% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| TSUB.F | US Pharmaceuticals | US Markt | |
|---|---|---|---|
| 7D | 0% | -1.7% | -0.9% |
| 1Y | n/a | 23.5% | 38.9% |
Rendement versus industrie: Insufficient data to determine how TSUB.F performed against the US Pharmaceuticals industry.
Rendement versus markt: Insufficient data to determine how TSUB.F performed against the US Market.
Prijsvolatiliteit
| TSUB.F volatility | |
|---|---|
| TSUB.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stabiele aandelenkoers: TSUB.F has not had significant price volatility in the past 3 months.
Volatiliteit in de loop van de tijd: Insufficient data to determine TSUB.F's volatility change over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2012 | 10 | Kazuo Tsubota | www.tsubota-lab.com |
Tsubota Laboratory Incorporated Samenvatting
| TSUB.F fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$81.46m |
| Inkomsten(TTM) | US$160.53k |
| Inkomsten(TTM) | US$5.02m |
507.5x
Koers/Winstverhouding16.2x
P/S-verhoudingIs TSUB.F overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| TSUB.F resultatenrekening (TTM) | |
|---|---|
| Inkomsten | JP¥750.00m |
| Kosten van inkomsten | JP¥87.00m |
| Brutowinst | JP¥663.00m |
| Overige uitgaven | JP¥639.00m |
| Inkomsten | JP¥24.00m |
Laatst gerapporteerde inkomsten
Jun 30, 2023
Volgende inkomensdatum
Nov 10, 2023
| Winst per aandeel (EPS) | 0.94 |
| Brutomarge | 88.40% |
| Nettowinstmarge | 3.20% |
| Schuld/Eigen Vermogen Verhouding | 7.2% |
Hoe presteerde TSUB.F op de lange termijn?
Bekijk historische prestaties en vergelijking